guest ::
| Home > Publications database > Piloting a cancer awareness app across six European countries: a pre-post study. > print |
| Home > Publications database > Piloting a cancer awareness app across six European countries: a pre-post study. > print |
| 001 | 305376 | ||
| 005 | 20251019023238.0 | ||
| 024 | 7 | _ | |a 10.3389/fpubh.2025.1648212 |2 doi |
| 024 | 7 | _ | |a pmid:41089856 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC12515922 |2 pmc |
| 024 | 7 | _ | |a altmetric:181794960 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2025-02117 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Ahmed, Furqan |b 0 |
| 245 | _ | _ | |a Piloting a cancer awareness app across six European countries: a pre-post study. |
| 260 | _ | _ | |a Lausanne |c 2025 |b Frontiers Media |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1760526066_2297 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Cancer remains a significant public health challenge in Europe, accounting for over 22% of global cancer cases. Mobile health applications may help to increase the awareness of cancer risks and preventive behaviors. However, usability barriers and disparities in digital health literacy (DHL) may limit their impact.This study evaluated the usability of the EU Mobile App for Cancer Prevention and changes in cancer awareness associated with use across six European countries (Cyprus, Germany, Hungary, Portugal, Slovenia, Spain), focusing on variations by DHL and sociodemographic factors.A pre-post design was employed, combining pre- and post-usage surveys (N = 328 pre; n = 77 post). Participants interacted with the app for 7 days. Usability was assessed via the System Usability Scale (SUS), cancer awareness via an 18-item quiz, and DHL using the eHEALS tool. Descriptive statistics summarized key variables, while t-tests and ANOVAs assessed group differences in usability and cancer awareness outcomes.A total of 328 participants completed the pre-usage survey, with 77 proceeding to the post-usage phase; the primary reason for dropout was technical difficulties. The app's overall usability was rated as moderate (Mean = 62.56 on the SUS) and did not differ significantly across demographic or usage subgroups. Cancer awareness scores improved from 50.45 to 53.31 (p < 0.001) showing significant moderate improvement, particularly among those with lower DHL and higher education. We observed no dose response relationship between self-reported app usage (frequency or session duration) and changes in cancer awareness.This pilot study demonstrates that the EU Mobile App for Cancer Prevention can enhance cancer awareness, while currently the usability was judged to be moderate. Targeted refinements in navigation, setup procedures, and content tailoring for low-DHL users are essential to improve engagement and ensure equitable reach. |
| 536 | _ | _ | |a 313 - Krebsrisikofaktoren und Prävention (POF4-313) |0 G:(DE-HGF)POF4-313 |c POF4-313 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
| 650 | _ | 7 | |a European Union |2 Other |
| 650 | _ | 7 | |a cancer prevention |2 Other |
| 650 | _ | 7 | |a digital health literacy |2 Other |
| 650 | _ | 7 | |a mobile health |2 Other |
| 650 | _ | 7 | |a pre-post study |2 Other |
| 650 | _ | 7 | |a usability |2 Other |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Mobile Applications: statistics & numerical data |2 MeSH |
| 650 | _ | 2 | |a Female |2 MeSH |
| 650 | _ | 2 | |a Male |2 MeSH |
| 650 | _ | 2 | |a Neoplasms: prevention & control |2 MeSH |
| 650 | _ | 2 | |a Europe |2 MeSH |
| 650 | _ | 2 | |a Middle Aged |2 MeSH |
| 650 | _ | 2 | |a Adult |2 MeSH |
| 650 | _ | 2 | |a Pilot Projects |2 MeSH |
| 650 | _ | 2 | |a Health Literacy |2 MeSH |
| 650 | _ | 2 | |a Health Knowledge, Attitudes, Practice |2 MeSH |
| 650 | _ | 2 | |a Surveys and Questionnaires |2 MeSH |
| 650 | _ | 2 | |a Aged |2 MeSH |
| 700 | 1 | _ | |a Romero Saletti, Silvana Melissa |b 1 |
| 700 | 1 | _ | |a D'Souza, Erica |b 2 |
| 700 | 1 | _ | |a Espina, Carolina |b 3 |
| 700 | 1 | _ | |a Ritchie, David |b 4 |
| 700 | 1 | _ | |a Barceló, Ana Molina |b 5 |
| 700 | 1 | _ | |a Carbó, Marina Pinto |b 6 |
| 700 | 1 | _ | |a Cervera, Paula Romeo |0 P:(DE-HGF)0 |b 7 |
| 700 | 1 | _ | |a Seum, Teresa |0 P:(DE-He78)cfc349d742aee6cc3394ccaa1ef6494f |b 8 |u dkfz |
| 700 | 1 | _ | |a Brenner, Hermann |0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2 |b 9 |u dkfz |
| 700 | 1 | _ | |a Van den Broucke, Stephan |b 10 |
| 700 | 1 | _ | |a Krini, Maria |b 11 |
| 700 | 1 | _ | |a Fonseca, Cristiana |b 12 |
| 700 | 1 | _ | |a Pinto, Patricia |b 13 |
| 700 | 1 | _ | |a Krivic, Diana |b 14 |
| 700 | 1 | _ | |a Comesana, Helena Ros |b 15 |
| 700 | 1 | _ | |a Yared, Wendy |b 16 |
| 700 | 1 | _ | |a Wiersing, Rebekka |b 17 |
| 700 | 1 | _ | |a Zeeb, Hajo |b 18 |
| 700 | 1 | _ | |a Brand, Tilman |b 19 |
| 773 | _ | _ | |a 10.3389/fpubh.2025.1648212 |g Vol. 13, p. 1648212 |0 PERI:(DE-600)2711781-9 |p 1648212 |t Frontiers in Public Health |v 13 |y 2025 |x 2296-2565 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:305376 |p VDB |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)cfc349d742aee6cc3394ccaa1ef6494f |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 9 |6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-313 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Krebsrisikofaktoren und Prävention |x 0 |
| 914 | 1 | _ | |y 2025 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b FRONT PUBLIC HEALTH : 2022 |d 2024-12-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2024-12-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2024-12-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2024-09-08T15:39:41Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2024-09-08T15:39:41Z |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Anonymous peer review |d 2024-09-08T15:39:41Z |
| 915 | _ | _ | |a Creative Commons Attribution CC BY (No Version) |0 LIC:(DE-HGF)CCBYNV |2 V:(DE-HGF) |b DOAJ |d 2024-09-08T15:39:41Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2024-12-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2024-12-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1180 |2 StatID |b Current Contents - Social and Behavioral Sciences |d 2024-12-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0130 |2 StatID |b Social Sciences Citation Index |d 2024-12-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2024-12-27 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2024-12-27 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2024-12-27 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b FRONT PUBLIC HEALTH : 2022 |d 2024-12-27 |
| 915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2024-12-27 |
| 915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2024-12-27 |
| 920 | 1 | _ | |0 I:(DE-He78)C070-20160331 |k C070 |l C070 Klinische Epidemiologie der Krebsfrüherkennung |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)C070-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|